PYPD

AS OF

Nov 13, 04:59 PM (EDT)

Price

$3.58

Change

-$0.17 (-4.53%)

Capitalization

59.61M

90 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

PYPD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYPD is expected to report earnings to rise 35.81% to -50 cents per share on February 11

Q4'25

Est.

$-0.50

Q3'25

Missed

by $0.04

Q2'25

Missed

by $0.21

Q1'25

Beat

by $0.22

Q4'24

Missed

by $0.22

The last earnings report on November 12 showed earnings per share of -37 cents, missing the estimate of -33 cents. With 11.45K shares outstanding, the current market capitalization sits at 59.61M.

View a ticker or compare two or three

Compare

PYPD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PYPD showed earnings on November 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading for PYPD

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com